MiMedx Group Inc (NAS:MDXG)
$ 6.13 -0.1 (-1.61%) Market Cap: 899.94 Mil Enterprise Value: 850.15 Mil PE Ratio: 9.81 PB Ratio: 5.35 GF Score: 76/100

Q2 2022 MiMedx Group Inc Earnings Call Transcript

Aug 03, 2022 / 12:30PM GMT
Release Date Price: $3.69 (+7.27%)
Operator

Greetings, and welcome to the MiMedx Group Second Quarter 2022 Operational and Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Jack Howarth, Senior Vice President Investor Relations from MiMedx Group. Thank you. You may begin.

John J. Howarth
MiMedx Group, Inc. - SVP of IR

Thank you, Operator. And good morning, everyone. Welcome to the MiMedx Second Quarter 2022 Operating and Financial Results Conference Call. With me on today's call, our Chief Executive Officer, Tim Wright; Chief Financial Officer, Pete Carlson; President Wound Care and Surgical, Dr. Rohit Kashyap; and President, Regenerative Medicine and Biologics Innovation, Dr. Robert Stein. Tim and Pete will provide a summary of our operating highlights and financial results for the quarter. And at the conclusion of their remarks, Tim, Pete and doctors Kashyap and Stein will be available for your questions.

Before we begin, I would like to remind you that our comments today

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot